Chemtatva Chiral Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -19.68%
- Profit Growth -84.08%
- Ebitda -24.95%
- Net Worth -9.63%
- Total Assets 105.05%
About Chemtatva Chiral Solutions
Chemtatva Chiral Solutions Private Limited (CCSPL) is a Private Limited Indian Non-Government Company incorporated in India on 04 February 2021 (Three years and 11 months 25 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Madana Daram, Vishal Rajput, and Vandana Chouhan serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U24299TG2021PTC148338
- Company No.
148338
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Feb 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Chemtatva Chiral Solutions?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Madana Daram  | Director | Current | |
| Vishal Rajput | Director | 30-Jan-2024 | Current |
| Vandana Chouhan | Director | Current |
Financial Performance of Chemtatva Chiral Solutions.
Chemtatva Chiral Solutions Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 19.68% decrease. The company also saw a substantial fall in profitability, with a 84.08% decrease in profit. The company's net worth dipped by a decrease of 9.63%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemtatva Chiral Solutions?
In 2023, Chemtatva Chiral Solutions had a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Glycan Life Sciences LlpVandana Chouhan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chemtatva Chiral Solutions?
Chemtatva Chiral Solutions has a workforce of 0 employees as of Jul 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemtatva Chiral Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemtatva Chiral Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
